241
Researchers in Sweden have developed a groundbreaking, cost-effective blood test that can quickly diagnose Alzheimer’s disease, potentially transforming the landscape of early detection and treatment. Dr. James Galvin, who heads the University of Miami’s Center for Brain Health, highlights the significance of this new development, emphasizing its potential to identify Alzheimer’s in its early stages, well before more invasive and expensive tests are required.
The new blood test is designed to detect biomarkers associated with the early stages of Alzheimer’s, allowing for earlier and. . .
